(Q37786623)

23 August 2017

title

Ketamine for the treatment of chronic non-cancer pain (English)

1 reference

23 August 2017

0 references

6

Albert Dahan

1 reference

23 August 2017

Ingeborg Noppers

1

1 reference

23 August 2017

Marieke Niesters

2

1 reference

23 August 2017

Leon Aarts

3

1 reference

23 August 2017

Terry Smith

4

1 reference

23 August 2017

Elise Sarton

5

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Pharmacotherapy

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

14

1 reference

23 August 2017

page(s)

2417-2429

1 reference

Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

NMDA receptors in clinical neurology: excitatory times ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

N-methyl-D-aspartate antagonists and neuropathic pain: the search for relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine in chronic pain management: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine for perioperative pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine for chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Use of oral ketamine in chronic pain management: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Stereoselective pharmacokinetics of ketamine: R(-)-ketamine inhibits the elimination of S(+)-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

An observational study on the effect of S+-ketamine on chronic pain versus experimental acute pain in Complex Regional Pain Syndrome type 1 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The involvement of the mu-opioid receptor in ketamine-induced respiratory depression and antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

HCN1 channel subunits are a molecular substrate for hypnotic actions of ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The Role of N-Methyl-d-Aspartate (NMDA) Receptors in Pain: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Effects of norketamine enantiomers in rodent models of persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Short- and long-term efficacy of oral ketamine in eight chronic-pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

N of 1 randomised controlled trials of oral ketamine in patients with chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Managing chronic whiplash associated pain with a combination of low-dose opioid (remifentanil) and NMDA-antagonist (ketamine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

A single infusion of intravenous ketamine improves pain relief in patients with critical limb ischaemia: results of a double blind randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Intravenous ketamine for CRPS: Making too much of too little?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

What is considered long-term pain relief in chronic pain management? Re: Sigtermans et al., Pain 2009;145:304-311.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Sympathomimetic effects of low-dose S(+)-ketamine. Effect of propofol dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Investigation of the potentiation of the analgesic effects of fentanyl by ketamine in humans: a double-blinded, randomised, placebo controlled, crossover study of experimental pain[ISRCTN83088383]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Pathologically activated therapeutics for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine : from medicine to misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Increased response to ketamine following treatment at long intervals: implications for intermittent use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine-induced neuronal cell death in the perinatal rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2010.515978

10.1517/14656566.2010.515978

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference